Skip to main content
SpringerLink
Log in

Clinical Experience in Children

  • Chapter
Tacrolimus Ointment

Abstract

Atopic dermatitis in children has become an important public health concern. The prevalence of the condition has trebled in the past 20 years, reaching 15%–20% in Western countries [16], and this continuing upward rise shows no signs of being reversed. Atopic dermatitis affects primarily infants and children, with the age of onset typically between 3 and 6 months old, and this is one of the major challenges in contemporary paediatric dermatology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aly R (1980) Bacteriology of atopic dermatitis. Acta Derm Venerol (Stockh) Suppl 92: 16–18

    Google Scholar 

  2. Bekersky I, Fitzsimmons W, Tanase A et al. (2001) Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 44(1): S17–27

    Article  PubMed  CAS  Google Scholar 

  3. Bode HH (1980) Dwarfism following long-term topical corticosteroid therapy. JAMA 244: 813–814

    Article  PubMed  CAS  Google Scholar 

  4. Boguniewicz M, Fiedler VC, Raimer S et al. (1998) A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 102: 637–644

    Article  PubMed  CAS  Google Scholar 

  5. Bos J, Smitt S (1996) Atopic dermatitis. J Eur Acad Dermatol Venereol 7: 101–114

    Article  CAS  Google Scholar 

  6. Bridgett C, Noren P, Staughton R (1996) Atopic skin disease. A manual for practitioners. Wrightson Biomedical Publishing, Petersfield

    Google Scholar 

  7. Drake L, Prendergast M, Maher R et al. (2001) The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 44: S65–72

    Article  PubMed  CAS  Google Scholar 

  8. Gunther S (1976) Incidence and degree of unwanted adverse effects of corticoids in children: results of dermatological studies in children with chronic diseases in the age group of 1–15 years. Z Hautkr 51: 569–579

    PubMed  CAS  Google Scholar 

  9. Hanifin JM, Thurston M, Omoto M et al. (2001) The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 10: 11–18

    Article  PubMed  CAS  Google Scholar 

  10. Hanifin J, Leung D, Palier A, Rico MJ (2003) Tacrolimus ointment monotherapy is safe and effective for the long-term treatment [more than 3 years] of atopic dermatitis in pediatric patients. 59th Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Denver, USA, March 7–12, abstract

    Google Scholar 

  11. Harris JM, Cullinan P, Williams HC et al. (2001) Environmental associations with eczema in early life. Br J Dermatol 144: 795–802

    Article  PubMed  CAS  Google Scholar 

  12. Hepburn D, Yohn JJ, Weston WL (1994) Topical steroid treatment in infants, children and adolescents. Adv Dermatol 9: 225–254; discussion 255

    PubMed  CAS  Google Scholar 

  13. Hill CJ, Rosenberg A Jr (1978) Adverse effects from topical steroids. Cutis 21: 624–628

    PubMed  CAS  Google Scholar 

  14. Kang S, Lucky A, Pariser D et al. (2001) Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 44: S58–64

    Article  PubMed  CAS  Google Scholar 

  15. Kawashima M, Harada S, Tamaki K (1997) A safety study of FK506 ointment in patients with atopic dermatitis. J Clin Ther Med 13: 1483–1492

    Google Scholar 

  16. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG (1994) The prevalence of childhood eczema in a general population. J Am Acad Dermatol 30: 35–39

    Article  PubMed  CAS  Google Scholar 

  17. Lewis-Jones MS, Finlay AY (1994) The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Clin Exp Dermatol 19: 210–216

    Article  Google Scholar 

  18. McLean C, Lobo R, Brazier D (1995) Cataracts, glaucoma, femoral avascular necrosis caused by topical corticosteroid ointment. Lancet 346: 1298

    PubMed  Google Scholar 

  19. Nakagawa H, Etoh T, Ishibashi Y et al. (1994) Tacrolimus ointment for atopic dermatitis. Lancet 344: 883

    Article  PubMed  CAS  Google Scholar 

  20. Ngheim P, Pearson G, Langley R (2002) Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 46: 228–241

    Article  Google Scholar 

  21. Palier A, Eichenfield LF, Leung IYM et al. (2001) A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatrie patients. J Am Acad Dermatol 44: S47–57

    Article  Google Scholar 

  22. de Prost Y, Bodemer C, Teillac D (1989) Double-blind randomized placebo-controlled trial of local cyclosporine in atopic dermatitis. Arch Dermatol 125: 570

    Article  PubMed  Google Scholar 

  23. Queille C, Pommarede R, Saurat JH (1984) Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1: 246–253

    Article  PubMed  CAS  Google Scholar 

  24. Raimer SS (2000) Managing pediatrie atopic dermatitis. Clin Pediatr 39: 1–14

    Article  CAS  Google Scholar 

  25. Reitamo S, Rissanen J, Remitz A et al. (1998) Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 111: 396–398

    Article  PubMed  CAS  Google Scholar 

  26. Reitamo S, van Leent EJM, Ho V et al. for the European Tacrolimus Ointment Study Group (2002) Efficacy and safety of tacrolimus ointment compared with hydrocortisone acetate in children with atopic dermatitis. J Allergy Clin Immunol 109: 539–546

    Article  PubMed  CAS  Google Scholar 

  27. Remitz A, Kyllonen H, Granlund H, Reitamo S (2001) Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 107: 196–197

    Article  PubMed  CAS  Google Scholar 

  28. de Rie MA, Meinardi MMHM, Bos JD (1991) Lack of effect of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta Derm Venereol 71: 452–454

    PubMed  Google Scholar 

  29. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C (1982) Cushing’s syndrome after topical application of corticosteroid. Am J Dis Child 136: 247–275

    Google Scholar 

  30. Stiehm ER, Roberts RL, Kaplan MS, Jonathan Corren J, Rico MJ, Parker JC (2003) Tacrolimus ointment does not alter the immune system of children aged 2–12. 59th Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Denver, USA, March 7–12, abstract

    Google Scholar 

  31. Undre NA, Stevenson P, Schafer A (1999) Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc 31: 7A 21S–24S

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Y. de Prost
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Düsseldorf Hautklinik, Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Germany

    Thomas Ruzicka

  2. Hospital for Skin and Allergic Diseases, Department of Dermatology, Helsinki University Central Hospital, Meilahdentie 2, 00250, Helsinki, Finland

    Sakari Reitamo

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

de Prost, Y. (2004). Clinical Experience in Children. In: Ruzicka, T., Reitamo, S. (eds) Tacrolimus Ointment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10209-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10209-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10211-4

  • Online ISBN: 978-3-662-10209-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation